［1］ HATAKEYAMA S.TRIM family proteins:Roles in autophagy,immunity,and carcinogenesis［J］.Trends in Biochemical Sciences,2017,42(4):297-311.
［2］ GU J,CHEN J,XIANG S,et al.Intricate confrontation:Research progress and application potential of TRIM family proteins in tumor immune escape［J］.Journal of Advanced Research,2023,54:147-179.
［3］ WATANABE M,HATAKEYAMA S.TRIM proteins and diseases［J］.Journal of Biochemistry,2017,161(2):135-144.
［4］ HOL JA,DIETS IJ,DE KRIJGER RR,et al.TRIM28 variants and Wilms' tumour predisposition［J］.The Journal of Pathology,2021,254(4):494-504.
［5］ CZERWINSKA P,MAZUREK S,WIZNEROWICZ M.The complexity of TRIM28 contribution to cancer［J］.J Biomed Sci,2017,24(1):63.
［6］ HATAKEYAMA S.TRIM proteins and cancer［J］.Nat Rev Cancer,2011,11(11):792-804.
［7］ MAZUREK S,OLEKSIEWICZ U,CZERWINSKA P,et al.Disruption of RING and PHD domains of TRIM28 evokes differentiation in human iPSCs［J］.Cells,2021,10(8):1933.
［8］ GEIS FK,GOFF SP.Silencing and transcriptional regulation of endogenous retroviruses:An overview［J］.Viruses,2020,12(8):884.
［9］ SONG X,GUO C,ZHENG Y,et al.Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells［J］.BMC Cancer,2018,18(1):971.
［10］ WANG C,IVANOV A,CHEN L,et al.MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation［J］.EMBO J,2005,24(18):3279-3290.
［11］ MA X,JIA S,WANG G,et al.TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance［J］.Signal Transduct Target Ther,2023,8(1):246.
［12］ YANG Y,LU H,CHEN C,et al.HIF-1 interacts with TRIM28 and DNA-PK to release paused RNA polymerase Ⅱ and activate target gene transcription in response to hypoxia［J］.Nature Communications,2022,13(1):316.
［13］ APPIKONDA S,THAKKAR KN,BARTON MC.Regulation of gene expression in human cancers by TRIM24［J］.Drug Discovery Today Technologies,2016,19:57-63.
［14］ FONG KW,ZHAO JC,SONG B,et al.TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression［J］.Nature Communications,2018,9(1):5007.
［15］ ZHAO Z,FENG L,PENG X,et al.Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response［J］.Frontiers in Pharmacology,2022,13:1073713.
［16］ WANG J,SONG X,GUO C,et al.Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells［J］.Cancer Science,2016,107(12):1888-1897.
［17］ SCIOT R.MDM2 amplified sarcomas:A literature review［J］.Diagnostics,2021,11(3):496.
［18］ JIN JO,LEE GD,NAM SH,et al.Sequential ubiquitination of p53 by TRIM28,RLIM,and MDM2 in lung tumorigenesis［J］.Cell Death Differ,2021,28(6):1790-1803.
［19］ TANG Q,CHEN Y,LI X,et al.The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers［J］.Frontiers in Immunology,2022,13:964442.
［20］ SEMENZA GL.HIF-1 and mechanisms of hypoxia sensing［J］.Current Opinion in Cell Biology,2001,13(2):167-171.
［21］ BACON CW,CHALLA A,HYDER U,et al.KAP1 is a chromatin reader that couples steps of RNA polymerase Ⅱ transcription to sustain oncogenic programs［J］.Molecular Cell,2020,78(6):1133-1151.e14.
［22］ KUMAR J,KAUR G,REN R,et al.KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells［J］.NAR Cancer,2020,2(2):zcaa007.
［23］ AGARWAL N,RINALDETTI S,CHEIKH BB,et al.TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer［J］.Proc Natl Acad Sci U S A,2021,118(38):e2102423118.
［24］ PARK HH,KIM HR,PARK SY,et al.RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment［J］.Molecular Cancer,2021,20(1):107.
［25］ BIAN Z,YAN J,WANG S,et al.Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles:Overcoming biological barriers to D-peptide drug delivery［J］.Theranostics,2018,8(19):5320-5335.
［26］ DING Z,PAN Y
,SHANG T,et al.URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers［J］.Nat Commun,2023,14(1):6269.
［27］ DOYLE JM,GAO J,WANG J,et al.MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases［J］.Mol Cell,2010,39(6):963-974.
［28］ BRABLETZ S,SCHUHWERK H,BRABLETZ T,et al.Dynamic EMT:a multi-tool for tumor progression［J］.EMBO J,2021,40(18):e108647.
［29］ WEI C,CHENG J,ZHOU B,et al.Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein［J］.Sci Rep,2016,6:29822.
［30］ CHEN L,MUNOZ-ANTONIA T,CRESS WD.TRIM28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines［J］.PLoS One,2014,9(7):e101040.
［31］ PINEDA CT,POTTS PR.Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer［J］.Autophagy,2015,11(5):844-846.
［32］ PENG Y,ZHANG M,JIANG Z,et al.TRIM28 activates autophagy and promotes cell proliferation in glioblastoma［J］.OncoTargets and Therapy,2019,12:397-404.
［33］ DUCHARTRE Y,KIM YM,KAHN M.The Wnt signaling pathway in cancer［J］.Critical Reviews in Oncology/Hematology,2016,99:141-149.
［34］ CUI J,HU J,YE Z,et al.TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis［J］.Science Bulletin,2019,64(14):986-997.
［35］ LI F,WANG Z,LU G.TRIM28 promotes cervical cancer growth through the mTOR signaling pathway［J］.Oncol Rep,2018,39(4):1860-1866.
［36］ CHEN Y,CHENG H,LONG H.Tripartite motif containing 28 (TRIM28) promotes the growth and migration of endometrial carcinoma cells by regulating the AKT/mTOR signaling pathway［J］.General Physiology and Biophysics,2023,40(03):245-252.
［37］ GUO YJ,PAN WW,LIU SB,et al.ERK/MAPK signalling pathway and tumorigenesis (Review)［J］.Experimental and Therapeutic Medicine,2020,19(3):1997-2007.
［38］ WU GJ,PEN J,HUANG Y,et al.KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells［J］.Molecular Carcinogenesis,2018,57(10):1396-1407.
［39］ TIAN Y,WAN N,ZHANG H,et al.Chemoproteomic mapping of the glycolytic targetome in cancer cells［J］.Nature Chemical Biology,2023,19(12):1480-1491.
［40］ KIM YS,POTASHNIKOVA DM,GISINA AM,et al.TRIM28 is a novel regulator of CD133 expression associated with cancer stem cell phenotype［J］.International Journal of Molecular Sciences,2022,23(17):9874.
［41］BRAY F,LAVERSANNE M,SUNG H, et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2024,74(3):229-263.
［42］ YOKOE T,TOIYAMA Y,OKUGAWA Y,et al.KAP1 is associated with peritoneal carcinomatosis in gastric cancer［J］.Annals of Surgical Oncology,2009,17(3):821-828.
［43］ ADDISON JB,KOONTZ C,FUGETT JH,et al.KAP1 promotes proliferation and metastatic progression of breast cancer cells［J］.Cancer Research,2015,75(2):344-355.
［44］ CZERWINSKA P,SHAH PK,TOMCZAK K,et al.TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development［J］.Oncotarget,2017,8(1):863-882.
［45］ ZHANG W,CAI Z,KONG M,et al.Prognostic significance of TRIM28 expression in patients with breast carcinoma［J］.Open Medicine,2021,16(1):472-480.
［46］ LIN LF,LI CF,WANG WJ,et al.Loss of ZBRK1 contributes to the increase of KAP1 and promotes KAP1-mediated metastasis and invasion in cervical cancer［J］.PLoS One,2013,8(8):e73033.
［47］ POPOVA NV,JUCKER M.The role of mTOR signaling as a therapeutic target in cancer［J］.Int J Mol Sci,2021,22(4):1743.
［48］ SCHABATH MB,COTE ML.Cancer progress and priorities:Lung cancer［J］.Cancer Epidemiol Biomarkers Prev,2019,28(10):1563-1579.
［49］ FERNANDEZ HR,GADRE SM,TAN M,et al.The mitochondrial citrate carrier,SLC25A1,drives stemness and therapy resistance in non-small cell lung cancer［J］.Cell Death Differ,2018,25(7):1239-1258.
［50］ LIU L,XIAO L,LIANG X,et al.TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer［J］.Oncology Reports,2017,37(6):3597-3605.
［51］ LIANG M,SUN Z,CHEN X,et al.E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells［J］.Journal of Experimental & Clinical Cancer Research,2023,42(1):275.
［52］ FITZGERALD S,ESPINA V,LIOTTA L,et al.Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment［J］.Journal of Translational Medicine,2018,16(1):89.
［53］ MOORE C,MONFORTE H,TEER JK,et al.TRIM28 congenital predisposition to Wilms' tumor:novel mutations and presentation in a sibling pair［J］.Molecular Case Studies,2020,6(4):a004796.
［54］ PRITCHARD-JONES K,HALLIDAY BJ,FUKUZAWA R,et al.Germline mutations and somatic inactivation of TRIM28 in Wilms tumour［J］.PLoS Genetics,2018,14(6):e1007399.
［55］ DIETS IJ,HOYER J,EKICI AB,et al.TRIM28 haplo insufficiency predisposes to Wilms tumor［J］.International Journal of Cancer,2019,145(4):941-951.
［56］ SU C,LI H,GAO W.TRIM28 is overexpressed in glioma and associated with tumor progression［J］.OncoTargets and Therapy,2018,11:6447-6458.
［57］ QI ZX,CAI JJ,CHEN LC,et al.TRIM28 as an independent prognostic marker plays critical roles in glioma progression［J］.Journal of Neuro-Oncology,2015,126(1):19-26.
［58］ CHANG YJ,KANG Z,BEI J,et al.Generation of TRIM28 knockout K562 cells by CRISPR/Cas9 genome editing and characterization of TRIM28-regulated gene expression in cell proliferation and hemoglobin beta subunits［J］.International Journal of Molecular Sciences,2022,23(12):6839.
［59］ CZERWINSKA P,JAWORSKA AM,WLODARCZYK NA,et al.Melanoma stem cell-like phenotype and significant suppression of immune response within a tumor are regulated by TRIM28 protein［J］.Cancers,2020,12(10):2998.
［60］ CUI Y,YANG S,FU X,et al.High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer［J］.International Journal of Molecular Sciences,2014,16(1):363-377.
［61］ TIAN Q,LU G,MA Y,et al.Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC［J］.Aging,2023,15(24):14617-14650.